Managing Bacteremia: Insights Into Pathogen-Specific Treatment

Area of Science:

• Infectious Diseases
• Clinical Pharmacology
• Antimicrobial Stewardship

Background:

• Traditional bacteremia treatment involves prolonged intravenous antibiotics.
• Recent evidence challenges these prolonged durations and IV-to-oral transition timing.
• Optimizing antibiotic therapy for bacteremia is crucial for patient outcomes and antimicrobial stewardship.

Purpose of the Study:

• To review recent evidence on bacteremia treatment duration.
• To outline strategies for transitioning from intravenous to oral antibiotic therapy.
• To provide guidance on managing Gram-positive and Gram-negative bacteremia.

Main Methods:

• Narrative review of current scientific literature.
• Integration of clinical guidelines and trial data.
• Analysis of pathogen-specific considerations.

Main Results:

• Evidence supports shorter antibiotic courses for uncomplicated bacteremia.
• Defined criteria exist for transitioning to oral therapy.
• Clinical decision-making frameworks are evolving.

Conclusions:

• Shorter antibiotic durations are increasingly supported by evidence.
• Judicious transition to oral therapy improves patient management.
• Updated strategies are essential for effective bacteremia treatment.